Our primary objectives are to investigate the causal relationship between obesity and IVDD and to identify the role of FABP4 in obesity‐induced IVDD and the molecular mechanisms by which FABP4 mediates ECM imbalance and angiogenesis. This evidence concerns the gene FABP4 and obesity due to melanocortin 4 receptor deficiency.